PMC:7781431 / 36111-36339 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1107","span":{"begin":10,"end":18},"obj":"Chemical"},{"id":"1113","span":{"begin":205,"end":226},"obj":"Disease"}],"attributes":[{"id":"A1107","pred":"tao:has_database_id","subj":"1107","obj":"MESH:D005395"},{"id":"A1113","pred":"tao:has_database_id","subj":"1113","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"he use of fish oil, an SPMs precursor, as an adjuvant are in progress. (Torrinhas et al. 2020; Rogero et al. 2020). SPMs and soluble epoxide hydrolase inhibitors are currently in clinical trials for other inflammatory diseases a"}

{"project":"LitCovid-sentences","denotations":[{"id":"T359","span":{"begin":89,"end":108},"obj":"Sentence"},{"id":"T360","span":{"begin":109,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"he use of fish oil, an SPMs precursor, as an adjuvant are in progress. (Torrinhas et al. 2020; Rogero et al. 2020). SPMs and soluble epoxide hydrolase inhibitors are currently in clinical trials for other inflammatory diseases a"}